THE BAJA POSTNEWSROOM The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) cancers called myelodysplastic syndromes … Sigue leyendo FDA Approves New Therapy for Myelodysplastic Syndromes, Rare Form of Blood Cancers